APA (7th ed.) Citation

Atanasova, E., Milosevic, D., Bornschlegl, S., Krucker, K. P., Jacob, E. K., Carmona Porquera, E. M., . . . Dietz, A. B. (2022). Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients. Stem Cell Research & Therapy, 13(1), 1. https://doi.org/10.1186/s13287-021-02692-0

Chicago Style (17th ed.) Citation

Atanasova, Elena, et al. "Normal Ex Vivo Mesenchymal Stem Cell Function Combined with Abnormal Immune Profiles Sets the Stage for Informative Cell Therapy Trials in Idiopathic Pulmonary Fibrosis Patients." Stem Cell Research & Therapy 13, no. 1 (2022): 1. https://doi.org/10.1186/s13287-021-02692-0.

MLA (9th ed.) Citation

Atanasova, Elena, et al. "Normal Ex Vivo Mesenchymal Stem Cell Function Combined with Abnormal Immune Profiles Sets the Stage for Informative Cell Therapy Trials in Idiopathic Pulmonary Fibrosis Patients." Stem Cell Research & Therapy, vol. 13, no. 1, 2022, p. 1, https://doi.org/10.1186/s13287-021-02692-0.